Re:A human monoclonal 1 antibody blocking SARS-CoV-2 infection
by nullc on Saturday March 14, 2020 @11:18PM
(#22580934)
For other coronaviruses that infect humans there the adaptive immune response isn't particularly strong and doesn't last. E.g. immunity to HCoV-OC43 lasts no more than about 12 months.
This is a reason to suspect that a vaccine may not be easily developed; so antibody therapy (and/or anti-virals) might be the best we can do.
If the antibody therapy was highly effective and could be produced at scale for a tolerable cost, it would probably be a pretty effective tool. Though monoclonal antibodies aren't known for being particularly affordable.
This is a reason to suspect that a vaccine may not be easily developed; so antibody therapy (and/or anti-virals) might be the best we can do.
If the antibody therapy was highly effective and could be produced at scale for a tolerable cost, it would probably be a pretty effective tool. Though monoclonal antibodies aren't known for being particularly affordable.